NCT05058508Recruiting
LCI-PED-NOS-EXER-001: Exercise in Pediatric Oncology Patients
LCI-PED-NOS-EXER-001: Just Move. A Randomized Controlled Trial Investigating Exercise in Pediatric Oncology Patients
Source: ClinicalTrials.gov · Last updated 22 Jul 2026
Brief summary (registry, in English)
The purpose of this study is to see if there are physical and emotional benefits to participating in a structured exercise regimen for those who are ages 2-25, are newly diagnosed with a blood or solid tumor cancer, and are currently undergoing or will begin cancer treatment.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- First submitted
- 14 Sept 2021
- Start date
- 11 Mar 2024
- Primary completion date
- 30 Nov 2027
- Lead sponsor
- Wake Forest University Health Sciences
- Diseases
- Childhood cancers
- NCT number
- NCT05058508
What you commit to
- Study type: Interventional
- Planned participants: 60
- From 11 Mar 2024 to the primary completion date, 30 Nov 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Recent (within 4 weeks of enrollment) or planned surgery that will result in prolonged limited mobility not amendable to exercise modifications per investigator discretion
Other illness
- Known cardiac dysfunction that, in the opinion of the investigator, would be unsafe for the child to participate in the exercise program
- Any other uncontrolled intercurrent illness/medical condition or psychiatric illness/social situations that would limit compliance with study requirements or would be considered unsafe for the child to participate as determined by the Investigator.
Other
- Primary CNS Tumor
- Osteosarcoma
Who the study is looking for
- Ages 2-25 at time of consent
- Subject has newly diagnosed cancer per Investigator, and is planning to undergo chemotherapy for treatment of malignancy for at least 3 full cycles
- Ability of subject (and/or parent/guardian) to read and understand the English or Spanish language
- As determined and documented by the enrolling investigator, ability of the subject to understand and comply with study procedures for the entire length of the study
- Subject has newly diagnosed cancer per Investigator and is planning to undergo chemotherapy, immunotherapy, or other systemically delivered for treatment of malignancy. Subjects are allowed to be enrolled up to 21 days after initiating cancer treatment.
- Receiving oncologic care at Levine Children's Cancer and Blood Disorders Clinic.
- Subject is anticipated to receive at least 3 full cycles of chemotherapy or other systemic cancer treatment.
- Not participating in another clinical trial that precludes participating in additional nondrug clinical trials.
Age in the registry: 2 years to 25 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Levine Children's Hospital Coordinator of this site? Confirm its status | Charlotte | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.